|
顯示項目 345826-345850 / 2347236 (共93890頁)
<< < 13829 13830 13831 13832 13833 13834 13835 13836 13837 13838 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2008 |
Durumolides A–E, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum
|
Duh, Chang-Yih; Chiang, Michael Y.; Dai, Chang-Feng; Wang, Shang-Kewi; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin; Wang, Shang-Kewi; Dai, Chang-Feng; Chiang, Michael Y.; Duh, Chang-Yih; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin |
| 臺大學術典藏 |
2020-05-26T09:26:29Z |
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|
Havel L; Pauk N; Singh J; Murakami S; Garassino M.C; Cho B.-C; Kim J.-H; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray J.E; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo R.A; Huang Y; Wadsworth C; Dennis P.A; Rizvi N.A; Paz-Ares Rodriguez L; Novello S; Hiret S; Schmid P; Laack E; Califano R; Maemondo M; Kim S.-W; Chaft J; Vicente Baz D; Berghmans T; Kim D.-W; Surmont V; Reck M; Han J.-Y; Holgado Martin E; Belda Iniesta C; Oe Y; Chella A; Chopra A; Robinet G; Soto Parra H; Thomas M; Cheema P; Katakami N; Su W.-C; Kim Y.-C; Wolf J; Lee J.-S; Saka H; Milella M; Ramos Garcia I; Sibille A; Yokoi T; Kang E.J; Atagi S; Spaeth-Schwalbe E; Nishio M; Imamura F; Gabrail N; Veillon R; Derijcke S; Maeda T; Zylla D; Kubiak K; Santoro A; Uy M.N; Lucien Geater S; Italiano A; Kowalski D; Barlesi F; Chen Y.-M; Spigel D; Chewaskulyong B; Garcia Gomez R; Alvarez Alvarez R; CHIH-HSIN YANG; Hsia T.-C; Denis F; Sakai H; Vincent M; Goto K; Bosch-Barrera J; Weiss G; Canon J.-L; Scholz C; Aglietta M; Kemmotsu H; Csoszi T; Losonczy G; Price A; Anderson I; Iqbal M; Torri V; Juhasz E; Khanani S; Koubkova L; Levy B; Page R; Bocskei C; Crinò L; Einspahr D; Hagenstad C; Juat N; Overton L; Garrison M; Szalai Z; ATLANTIC Investigators; Azuma K; Bradbury P; Feld R; Chachoua A; Jassem J; Juergens R; Palmero Sanchez R; Malcolm A; Vrindavanam N; Kubota K; Waller C; Waterhouse D; Coudert B; Mark Z; Satouchi M; Chang G.-C; Herzmann C; Chaudhry A; Giridharan S; Hesketh P; Ikeda N; Boccia R; Iannotti N; Haigentz M; Reynolds J; Querol J; Nakagawa K; Sugawara S; Tan E.H; Hirashima T; Gettinger S; Kato T; Takeda K; Juan Vidal O; Mohn-Staudner A; Panwalkar A; Daniel D; Kobayashi K; Ladrera G.E.I; Schulte C; Sebastian M; Cernovska M; Coupkova H; Juat N;Hagenstad C;Einspahr D;Crin? L;Bocskei C;Page R;Levy B;Koubkova L;Khanani S;Juhasz E;Torri V;Iqbal M;Anderson I;Price A;Losonczy G;Csoszi T;Murakami S;Singh J;Pauk N;Havel L;Coupkova H;Cernovska M;Sebastian M;Schulte C;Ladrera G.E.I;Kobayashi K;Daniel D;Panwalkar A;Mohn-Staudner A;Juan Vidal O;Takeda K;Kato T;Gettinger S;Hirashima T;Tan E.H;Sugawara S;Nakagawa K;Querol J;Reynolds J;Haigentz M;Iannotti N;Boccia R;Ikeda N;Hesketh P;Giridharan S;Chaudhry A;Herzmann C;Chang G.-C;Satouchi M;Mark Z;Coudert B;Waterhouse D;Waller C;Kubota K;Vrindavanam N;Malcolm A;Palmero Sanchez R;Juergens R;Jassem J;Chachoua A;Feld R;Bradbury P;Azuma K;Kemmotsu H;Aglietta M;Scholz C;Canon J.-L;Weiss G;Bosch-Barrera J;Goto K;Vincent M;Sakai H;Denis F;Hsia T.-C;Chih-Hsin Yang;Alvarez Alvarez R;Garcia Gomez R;Chewaskulyong B;Spigel D;Chen Y.-M;Barlesi F;Kowalski D;Italiano A;Lucien Geater S;Uy M.N;Santoro A;Kubiak K;Zylla D;Maeda T;Derijcke S;Veillon R;Gabrail N;Imamura F;Nishio M;Spaeth-Schwalbe E;Atagi S;Kang E.J;Yokoi T;Sibille A;Ramos Garcia I;Milella M;Saka H;Lee J.-S;Wolf J;Kim Y.-C;Su W.-C;Katakami N;Atlantic Investigators;Szalai Z;Garrison M;Overton L;Cheema P;Thomas M;Soto Parra H;Robinet G;Chopra A;Chella A;Oe Y;Belda Iniesta C;Holgado Martin E;Han J.-Y;Reck M;Surmont V;Kim D.-W;Berghmans T;Vicente Baz D;Chaft J;Kim S.-W;Maemondo M;Califano R;Laack E;Schmid P;Hiret S;Novello S;Paz-Ares Rodriguez L;Rizvi N.A;Dennis P.A;Wadsworth C;Huang Y;Soo R.A;Park K;Wheatley-Price P;Bidoli P;Chouaid C;Powderly J;Gray J.E;Corral Jaime J;Lena H;Vansteenkiste J;Mazi?res J;Kim J.-H;Cho B.-C;Garassino M.C |
| 國立成功大學 |
2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
|
Oh;Do-Youn;He;Ruth, Aiwu;Bouattour;Mohamed;Okusaka;Takuji;Qin;Shukui;Chen;Li-Tzong;Kitano;Masayuki;Lee;Choong-kun;Kim;Won, Jin;Chen;-Huang, Ming;Suksombooncharoen;Thatthan;Ikeda;Masafumi;Lee;Ah, Myung;Chen;Jen-Shi;Potemski;Piotr;Burris;Howard, A.;Ostwal;Vikas;Tanasanvimon;Suebpong;Morizane;Chigusa;Zaucha;Renata, E.;Mcnamara;Mairead, G.;Avallone;Antonio;Cundom;Juan, E.;Breder;Valeriy;Tan;Benjamin;Shimizu;Satoshi;Tougeron;David;Evesque;Ludovic;Petrova;Mila;Zhen;David, B.;Gillmore;Roopinder;Gupta;Govinda, Vineet;Dayyani;Farshid;Park;Oh, Joon;Jr, Buchschacher;Gary, L.;Rey;Felipe;Kim;Hyosung;Wang;Julie;Morgan;Claire;Rokutanda;Nana;Zotkiewicz;Magdalena;Vogel;Arndt;Valle;Juan, W. |
| 國家衛生研究院 |
2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study
|
Oh, DY;He, AR;Bouattour, M;Okusaka, T;Qin, S;Chen, LT;Kitano, M;Lee, CK;Kim, JW;Chen, MH;Suksombooncharoen, T;Ikeda, M;Lee, MA;Chen, JS;Potemski, P;Burris, HA, 3rd;Ostwal, V;Tanasanvimon, S;Morizane, C;Zaucha, RE;McNamara, MG;Avallone, A;Cundom, JE;Breder, V;Tan, B;Shimizu, S;Tougeron, D;Evesque, L;Petrova, M;Zhen, DB;Gillmore, R;Gupta, VG;Dayyani, F;Park, JO;Buchschacher, GL, Jr.;Rey, F;Kim, H;Wang, J;Morgan, C;Rokutanda, N;Żotkiewicz, M;Vogel, A;Valle, JW |
| 國立成功大學 |
2024 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
|
Oh;D, -Y.;He;A, R.;Bouattour;M;Okusaka;T;Qin;S;Chen;L, -T.;Kitano;M;Lee;C, -K.;Kim;J, W.;Chen;M, -H.;Suksombooncharoen;T;Ikeda;M;Lee;M, -A.;Chen;J, -S.;Potemski;P;Burris;H, A.;Ostwal;V;Tanasanvimon;S;Morizane;C;Zaucha;R, E.;McNamara;M, G.;Avallone;A;Cundom;J, E.;Breder;V;Tan;B;Shimizu;S;Tougeron;D;Evesque;L;Petrova;M;Zhen;D, B.;Gillmore;R;Gupta;V, G.;Dayyani;F;Park;J, O.;Buchschacher;G, L.;Rey;F;Kim;H;Wang;J;Morgan;C;Rokutanda;N;Żotkiewicz;M;Vogel;A;Valle;J, W. |
| 國家衛生研究院 |
2025-05-15 |
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
|
Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, R;Avallone, A;Cundom, J;Kuzko, A;Wang, J;Xynos, I;Vogel, A;Valle, JW |
| 國家衛生研究院 |
2025-02 |
Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE)
|
Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J |
| 國立臺灣大學 |
1993 |
Dusformone and Dischidiol from Dischida Formosana
|
Chen, Z. S.; Lee, G. H.; 郭悅雄; Chen, Z. S.; Lee, G. H.; Kuo, Yueh-Hsiung |
| 國立成功大學 |
2013-08-27 |
dusfusion 在邊境細胞的功能分析
|
吳榛惟; Wu, Jhen-Wei |
| 國立成功大學 |
2013-07-19 |
dusfusion 在邊境細胞的功能分析
|
吳榛惟; Wu, Jhen-Wei |
| 國立臺灣大學 |
2015 |
DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers
|
Lin, Yun-Chieh; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow; 張逸良; 施金元; 陳青周 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin, Yun-Chieh;Lin, Yu-Chin;Shih, Jin-Yuan;Huang, Wei-Jan;Chao, Shi-Wei;Chang, Yih-Leong;Chen, Ching-Chow; Lin, Y.-C. and Lin, Y.-C. and Shih, J.-Y. and Huang, W.-J. and Chao, S.-W. and Chang, Y.-L. and Chen, C.-C.; 張逸良;施金元;陳青周; YIH-LEONG CHANG; Lin, Yun-Chieh; JIN-YUAN SHIH; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow |
| 臺大學術典藏 |
2020-03-06T05:26:13Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.;Lin Y.-C.;Shih J.-Y.;Huang W.-J.;Chao S.-W.;Yih-Leong Chang;Chen C.-C.; Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:43Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.; Lin Y.-C.; JIN-YUAN SHIH; Huang W.-J.; Chao S.-W.; Chang Y.-L.; Chen C.-C. |
| 臺大學術典藏 |
2021-05-07T05:13:26Z |
DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers
|
Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; Chang Y.-L.; CHING-CHOW CHEN |
| 國家衛生研究院 |
2020-08-12 |
DUSP11 attenuates lipopolysaccharide-induced macrophage activation by targeting TAK1
|
Yang, CY;Chuang, HC;Tsai, CY;Xiao, YZ;Yang, JY;Huang, RH;Shih, YC;Tan, TH |
| 國家衛生研究院 |
2020-01 |
DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination
|
Wang, CA;Chang, IH;Hou, PC;Tai, YJ;Li, WN;Hsu, PL;Wu, SR;Chiu, WT;Li, CF;Shan, YS;Tsai, SJ |
| 國立成功大學 |
2020-01-1 |
DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination
|
Wang;Chu-An;Chang;I-Heng;Hou;Pei-Chi;Tai;Yu-Jing;Li;Wan-Ning;Hsu;Pei-Ling;Wu;Shang-Rung;Chiu;Wen-Tai;Li;Chien-Feng;Shan;Yan-Shen;Tsai;Shaw-Jenq |
| 國家衛生研究院 |
2024-06-14 |
DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling
|
Lin, HH;Chang, CW;Liao, YT;Yeh, SD;Lin, HP;Ho, HM;Cheung, CHY;Juan, HF;Chen, YR;Su, YW;Chen, LM;Tan, TH;Lin, WJ |
| 國家衛生研究院 |
2019-12 |
DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis
|
Lin, HP;Ho, HM;Chang, CW;Yeh, SD;Su, YW;Tan, TH;Lin, WJ |
| 國立成功大學 |
2024-08 |
DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1-immunophenotype
|
Chen;Bo-Jung;Hsieh;Shu-Min;Hsieh;Tsung-Han;Jhuang;Jie-Yang;Kao;Yu-Chien |
| 國立成功大學 |
2024 |
DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1− immunophenotype
|
Chen;B, -J.;Hsieh;S, -M.;Hsieh;T, -H.;Jhuang;J, -Y.;Kao;Y, -C. |
| 國家衛生研究院 |
2022-06-15 |
DUSP3 regulates phosphorylation-mediated degradation of occludin and is required for maintaining epithelial tight junction
|
Chou, HC;Cheng, CM;Yang, CH;Lin, TY;Liu, YW;Tan, TH;Chen, YR |
| 國家衛生研究院 |
2012-02 |
DUSP4 deficiency enhances CD25 expression and CD4(+) T-cell proliferation without impeding T-cell development
|
Huang, CY;Lin, YC;Hsiao, WY;Liao, FH;Huang, PY;Tan, TH |
顯示項目 345826-345850 / 2347236 (共93890頁)
<< < 13829 13830 13831 13832 13833 13834 13835 13836 13837 13838 > >>
每頁顯示[10|25|50]項目
|
